2025-521062-10-00招募中1 期
A Study to Evaluate the Safety and Tolerability of ARV-806 in Adults with Advanced Cancer that has the KRAS G12D Mutation
Arvinas Operations Inc.6 个研究点 分布在 2 个国家目标入组 51 人开始时间: 2026年4月15日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 51
- 试验地点
- 6
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Executive Medical Director, Clinical Development - Oncology
Scientific
Arvinas Operations Inc.
研究点 (6)
Loading locations...
相似试验
已完成
1 期
A Study to Evaluate the Safety and Tolerability of JNJ-77730614 When Given as Single and Multiple Doses to Healthy Participants to Assess How Long JNJ 77730614 Stays in the Body (Pharmacokinetics) and How the Body Responds to it (Pharmacodynamics)2023-505684-36-00Janssen - Cilag International92
招募中
1 期
A Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants2025-524310-28-00Quralis Corp.48
招募中
1 期
A study to evaluate the safety and tolerability of single ascending doses of AGMB-101 in healthy participants (Part A) and patients with liver cirrhosis (Part B).2024-515074-26-00AgomAb Therapeutics64
招募中
1 期
A study on the safety, tolerability, and effectiveness of the new drug LAD106 in healthy volunteers.2025-523328-31-00Almirall S.A.93
招募中
1 期
Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies2024-514938-20-00Regeneron Pharmaceuticals Inc.65